CoviGlobulin
CoviGlobulin Uses, Dosage, Side Effects, Food Interaction and all others data.
CoviGlobulin, a rabbit polyclonal antibody, was specifically designed as a potential therapy for COVID-19. Rabbit polyclonal antibodies are derived from the rabbit, a common animal host for polyclonal production. The antibodies themselves are produced in response to an immunogen and derived from antibody-producing plasma cells that were once B-cell clones. Different antibodies have different mechanisms of action depending on their target. Current applications of antibodies include, but are not limited to, targeting cancer, inflammatory diseases, organ transplantation, cardiovascular disease, infection, respiratory disease, and ophthalmologic disease.
| Trade Name | CoviGlobulin |
| Generic | CoviGlobulin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How CoviGlobulin works
No information available thus far on the MoA for CoviGlobulin.
Innovators Monograph
You find simplified version here CoviGlobulin
